Luke Miels' first financial results since taking over as chief executive of GSK revealed a jump in sales and profits, fuelled ...

Pfizer Inc. (NYSE:PFE) Q4 2025 Earnings Call Transcript February 3, 2026 Pfizer Inc. beats earnings expectations. Reported ...

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

PFE shares fall even after Q4 earnings beat on COVID product declines and muted investor reaction to new obesity drug data.

The recommended childhood and adolescent immunization schedule for the United States for 2026 has been issued by the AAP.

Pharmaceutical company’s stock price move diverges from rival Merck as both groups bolster new treatment pipelines ...

Pfizer reported a quarterly loss Tuesday following a large write-down, denting shares as it confirmed 2026 financial targets with lower revenues.

Pfizer posted adjusted earnings of 66 cents per share, beating the 57 cents forecast by analysts, News.Az reports, citing foreign ...

To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver ...

After advancing in lockstep through the pandemic, the fortunes of the biotechs have diverged as their use of COVID-19 windfalls has taken shape.

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

Get all the latest news and updates on Western Countries only on News18.com. Read Politics news, current affairs and news headlines online on Western Countries News today.